DOSSIER · 13F-HR · Q2 2026

Defilade Capital Management, L.P.

$747M in tracked AUM across 39 positions as of Q2 2026.

DC
CIK 0002088557 · last filed Jun 30, 2026
Total AUM
$747M
as of Q2 2026
Holdings
39
positions
Whale Score
60
60
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026

Defilade Capital Management, L.P. filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
LLY
ELI LILLY & CO
$47M39K6.3%
02
PFE
PFIZER INC
$43M1.8M5.7%
03
VEEV
VEEVA SYS INC
$42M237K5.6%
04
BMRN
BIOMARIN PHARMACEUTICAL INC
$39M682K5.2%
05
PTCT
PTC THERAPEUTICS INC
$35M434K4.7%
06
BAX
BAXTER INTL INC
$31M1.5M4.2%
07
INSM
INSMED INC
$30M282K4.0%
08
ZBH
ZIMMER BIOMET HOLDINGS INC
$27M317K3.7%
09
PODD
INSULET CORP
$27M177K3.6%
10
TMO
THERMO FISHER SCIENTIFIC INC
$26M52K3.5%

Filing history

2026Q2Jun 30
$747M 4.9%
39 positionsView →
2026Q1Mar 31
$712M 3.5%
31 positionsView →
2025Q4Dec 31
$738M
33 positionsView →